2
Oct
2025
Pfizer Buys Metsera GLP-1s, Genmab Nabs Merus for $8B, & Sanofi Commits to VC
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.
2
Oct
2025
Cartography Secures $67M for T-cell Engager for Colorectal Cancer (and a Platform, Too)
Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $199 per year, you reward quality independent biotech reporting, and encourage more. Subscribe Now Sign in to your account.